BRI Sponsors Annual Poultry Science Meeting

BRI was a Silver Level Sponsor at the Annual Meeting of the Poultry Science Association (PSA) held July 14-17 in Corpus Christi, TX and was the exclusive sponsor of the Asia-Pacific Luncheon on Wednesday, July 16. Alongside newly appointed PSA President Todd Applegate, Executive Director Stephen Koenig and other PSA Board Members, BRI CEO Giles…

Details

BioResource International, Inc. Granted FAMI-QS Certification for Quality and Safety in Feed Additives

RESEARCH TRIANGLE PARK, N.C.—June 9, 2014 —BioResource International, Inc. (BRI), an agricultural biotechnology company specializing in the research and development of enzymes, has received the European Feed Additives and Premixtures Quality System Certification (FAMI-QS) for its manufacturing facility in Apex, N.C. The audit was conducted by Underwriter’s Laboratories, Inc. and Deutsch Quality Systems (UL-DQS), a…

Details

BRI Receives Recognition at Triangle Life Sciences Award Event

RESEARCH TRIANGLE PARK, N.C.—May 22, 2014— BioResource International, Inc (BRI), an RTP-based agricultural biotechnology company, has been named “Best Agricultural Biotechnology” company at the second annual Triangle Business Journal Life Sciences Awards event. The awards recognize both individuals and organizations that are breaking new ground in the life sciences. BRI CEO Giles Shih accepted the…

Details

BRI Featured in National Report on Technology Transfer from University to Industry

The Better World Project, an initiative launched by the Association of University Technology Managers to promote public understanding of how academic research and technology transfer benefit millions of people around the world, recently interviewed BioResource International Inc. (BRI) CEO Dr. Giles Shih to discuss the innovative technology behind BRI.

To read the full article, click here.

BioResource International, Inc Expands Enzyme Portfolio with Launch of Xylamax™

RESEARCH TRIANGLE PARK, N.C.—March 31, 2014— RTP-based agricultural biotechnology company BioResource International, Inc. (BRI) announces the launch of Xylamax™, its latest high performance enzyme created to help producers economically deliver more meat in a safe and sustainable way. Xylamax is an intrinsically thermo-stable 1,4-beta-xylanase enzyme that delivers consistently high levels of energy release and improved…

Details

BioResource International, Inc Granted Good Manufacturing Practices Certification

RESEARCH TRIANGLE PARK, N.C.—February 21, 2014—BioResource International, Inc. (BRI), an agricultural biotechnology company specializing in the research and development of enzymes, has received the Good Manufacturing Practices (GMP) Certification for its manufacturing facility in Apex, North Carolina. Certification was granted by SGS International, the recognized global authority in certification of food manufacturing processes and safety…

Details

BRI Expands Enzyme Research and Development Credentials

BioResource International, Inc. (BRI), an agricultural biotechnology company specializing in the research and development of enzymes, has been awarded another US patent. With the new patent, the company expands its intellectual property portfolio in enzyme technology to include the use of its proprietary protease feed additive in both poultry and swine diets. “This patent allows…

Details

BRI Sponsors 20th Annual Taste of Hope Gala

BioResource International, Inc. (BRI) continues its support of the Inter-Faith Food Shuttle through sponsorship of the 20th Annual Taste of Hope Gala that was held on January 26th at the Umstead Hotel and Spa in Cary, North Carolina. BRI has supported the organization since 2009. “Our dedication to feeding the world starts at home and…

Details

BRI Develops High Performance Enzyme Additive to Reduce Poultry Feed Costs

BioResource International, Inc.’s newest enzyme, Xylamax™, is a proprietary thermo-stable mono-component xylanase enzyme proven to improve energy absorption in both wheat and corn/soy poultry diets, resulting in lower feed costs and improved return on investment. Multiple independent animal field trials conducted to date have consistently shown kcal/kg AME improvement levels above current industry norms.  The most…

Details